Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Clinical Pharmacokinetics
|
December 12, 2001
Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations
R G Thorne, W H Frey
Nature Materials
|
October 1, 2005
Diffusion measurements for drug design
R G Thorne, S Hrabetová, C Nicholson
Neuroscience
|
July 21, 2004
Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration
R G Thorne, G J Pronk, V Padmanabhan, et al.
Neuroscience Letters
|
July 18, 2001
Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion
X F Liu, J R Fawcett, R G Thorne, et al.
Brain Research
|
September 18, 1995
Quantitative analysis of the olfactory pathway for drug delivery to the brain
R G Thorne, C R Emory, T A Ala, et al.
Neuroscience
|
February 29, 2008
Delivery of interferon-beta to the monkey nervous system following intranasal administration
R G Thorne, L R Hanson, T M Ross, et al.
Journal of the Neurological Sciences
|
July 7, 2001
Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage
X F Liu, J R Fawcett, R G Thorne, et al.
Inorganic Chemistry
|
April 2, 2002
Third-order nonlinear optical properties of complexes with MM triple and quadruple bonds (M = Mo, W) at 1064 nm by degenerate four-wave mixing
Brian D Pate, Jonathan R G Thorne, Damon R Click, et al.
Journal of the American Chemical Society
|
August 15, 2002
Amplified optical nonlinearity in a self-assembled double-strand conjugated porphyrin polymer ladder
Thomas E O Screen, Jonathan R G Thorne, Robert G Denning, et al.
Journal of Neuroimmunology
|
May 18, 2004
Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis
T M Ross, P M Martinez, J C Renner, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Clinical Pharmacokinetics
|
December 12, 2001
Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations
R G Thorne, W H Frey
Nature Materials
|
October 1, 2005
Diffusion measurements for drug design
R G Thorne, S Hrabetová, C Nicholson
Neuroscience
|
July 21, 2004
Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration
R G Thorne, G J Pronk, V Padmanabhan, et al.
Neuroscience Letters
|
July 18, 2001
Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion
X F Liu, J R Fawcett, R G Thorne, et al.
Brain Research
|
September 18, 1995
Quantitative analysis of the olfactory pathway for drug delivery to the brain
R G Thorne, C R Emory, T A Ala, et al.
Neuroscience
|
February 29, 2008
Delivery of interferon-beta to the monkey nervous system following intranasal administration
R G Thorne, L R Hanson, T M Ross, et al.
Journal of the Neurological Sciences
|
July 7, 2001
Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage
X F Liu, J R Fawcett, R G Thorne, et al.
Inorganic Chemistry
|
April 2, 2002
Third-order nonlinear optical properties of complexes with MM triple and quadruple bonds (M = Mo, W) at 1064 nm by degenerate four-wave mixing
Brian D Pate, Jonathan R G Thorne, Damon R Click, et al.
Journal of the American Chemical Society
|
August 15, 2002
Amplified optical nonlinearity in a self-assembled double-strand conjugated porphyrin polymer ladder
Thomas E O Screen, Jonathan R G Thorne, Robert G Denning, et al.
Journal of Neuroimmunology
|
May 18, 2004
Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis
T M Ross, P M Martinez, J C Renner, et al.
Page
of 1